These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Localization and functional significance of striatal neurons immunoreactive to aromatic L-amino acid decarboxylase or tyrosine hydroxylase in rat Parkinsonian models. Lopez-Real A, Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL. Brain Res; 2003 Apr 18; 969(1-2):135-46. PubMed ID: 12676374 [Abstract] [Full Text] [Related]
24. Aromatic L-amino acid decarboxylase deficiency with hyperdopaminuria. Clinical and laboratory findings in response to different therapies. Fiumara A, Bräutigam C, Hyland K, Sharma R, Lagae L, Stoltenborg B, Hoffmann GF, Jaeken J, Wevers RA. Neuropediatrics; 2002 Aug 18; 33(4):203-8. PubMed ID: 12368991 [Abstract] [Full Text] [Related]
25. A novel compound heterozygous genotype associated with aromatic amino acid decarboxylase deficiency: Clinical aspects and biochemical studies. Montioli R, Battini R, Paiardini A, Tolve M, Bertoldi M, Carducci C, Leuzzi V, Borri Voltattorni C. Mol Genet Metab; 2019 Jun 18; 127(2):132-137. PubMed ID: 31104889 [Abstract] [Full Text] [Related]
26. Dopamine but not l-dopa stimulates neural glutathione metabolism. Potential implications for Parkinson's and other dopamine deficiency states. Allen GF, Ullah Y, Hargreaves IP, Land JM, Heales SJ. Neurochem Int; 2013 Apr 18; 62(5):684-94. PubMed ID: 23261515 [Abstract] [Full Text] [Related]
27. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats. Treseder SA, Rose S, Jenner P. Eur J Neurosci; 2001 Jan 18; 13(1):162-70. PubMed ID: 11135014 [Abstract] [Full Text] [Related]
28. L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase. Shimamura M, Shimizu M, Yagami T, Funabashi T, Kimura F, Kuroiwa Y, Misu Y, Goshima Y. Neuropharmacology; 2006 Jun 18; 50(8):909-16. PubMed ID: 16504219 [Abstract] [Full Text] [Related]
29. Aromatic L-amino acid decarboxylase deficiency in countries in the Middle East: a case series and literature review. Abukhaled M, Al Muqbil M, Alghamdi MA, Hundallah K, Suleiman J, Ben-Omran T, Alfadhel M, Almannai M, Alsaleh R, Tabarki B. Eur J Pediatr; 2023 Jun 18; 182(6):2535-2545. PubMed ID: 36928758 [Abstract] [Full Text] [Related]
30. Human aromatic amino acid decarboxylase is an asymmetric and flexible enzyme: Implication in aromatic amino acid decarboxylase deficiency. Bisello G, Ribeiro RP, Perduca M, Belviso BD, Polverino De' Laureto P, Giorgetti A, Caliandro R, Bertoldi M. Protein Sci; 2023 Aug 18; 32(8):e4732. PubMed ID: 37466248 [Abstract] [Full Text] [Related]
31. Semi-quantitative detection of a vanillactic acid/vanillylmandelic acid ratio in urine is a reliable diagnostic marker for aromatic L-amino acid decarboxylase deficiency. Brennenstuhl H, Garbade SF, Okun JG, Feyh P, Hoffmann GF, Langhans CD, Opladen T. Mol Genet Metab; 2020 Aug 18; 131(1-2):163-170. PubMed ID: 32675002 [Abstract] [Full Text] [Related]
32. A new perspective on the treatment of aromatic L-amino acid decarboxylase deficiency. Allen GF, Land JM, Heales SJ. Mol Genet Metab; 2009 May 18; 97(1):6-14. PubMed ID: 19231266 [Abstract] [Full Text] [Related]
33. Selective Serotonin Reuptake Inhibitor Treatment Post Gene Therapy for an Ultrarare Neurometabolic Disorder (AADC Deficiency). Baribeau DA, Vorstman JAS, Pearson TS. J Am Acad Child Adolesc Psychiatry; 2024 Jun 18; 63(6):571-573. PubMed ID: 38460745 [Abstract] [Full Text] [Related]
34. Neurodegenerative Etiology of Aromatic L-Amino Acid Decarboxylase Deficiency: a Novel Concept for Expanding Treatment Strategies. Sternberg Z. Mol Neurobiol; 2024 May 18; 61(5):2996-3018. PubMed ID: 37953352 [Abstract] [Full Text] [Related]
35. Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine. Mura A, Jackson D, Manley MS, Young SJ, Groves PM. Brain Res; 1995 Dec 15; 704(1):51-60. PubMed ID: 8750961 [Abstract] [Full Text] [Related]
36. Localization of L-DOPA uptake and decarboxylating neuronal structures in the cat brain using dopamine immunohistochemistry. Kitahama K, Geffard M, Araneda S, Arai R, Ogawa K, Nagatsu I, Pequignot JM. Brain Res; 2007 Sep 05; 1167():56-70. PubMed ID: 17692830 [Abstract] [Full Text] [Related]
38. The influence of L-dopa on methylation capacity in aromatic L-amino acid decarboxylase deficiency: biochemical findings in two patients. Bräutigam C, Wevers RA, Hyland K, Sharma RK, Knust A, Hoffman GF. J Inherit Metab Dis; 2000 Jun 05; 23(4):321-4. PubMed ID: 10896284 [No Abstract] [Full Text] [Related]
39. Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency. Wassenberg T, Molero-Luis M, Jeltsch K, Hoffmann GF, Assmann B, Blau N, Garcia-Cazorla A, Artuch R, Pons R, Pearson TS, Leuzzi V, Mastrangelo M, Pearl PL, Lee WT, Kurian MA, Heales S, Flint L, Verbeek M, Willemsen M, Opladen T. Orphanet J Rare Dis; 2017 Jan 18; 12(1):12. PubMed ID: 28100251 [Abstract] [Full Text] [Related]
40. Aromatic L-amino acid decarboxylase deficiency in Taiwan. Lee HF, Tsai CR, Chi CS, Chang TM, Lee HJ. Eur J Paediatr Neurol; 2009 Mar 18; 13(2):135-40. PubMed ID: 18567514 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]